Press Releases
Search
-
24 Jun 2021
In the fight against Antimicrobial Resistance, bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe
Marcy l’Étoile, France and Mountain View, California – bioMérieux, a world leader in the field of in vitro diagnostics, and Specific Diagnostics, a company bringing unique in vitro diagnostic systems ...
-
07 May 2021
bioMérieux announces the CE marking of the new generation semi-quantitative VIDAS® SARS-COV-2 IgG II serology test.
bioMérieux, a world leader in the field of in vitro diagnostics, today announces CE marking of the new generation of IgG serology test with VIDAS® SARS-COV-2 IgG II to semi-quantitatively detect antib...
-
30 Apr 2021
bioMérieux announces CE-marking of the new MALDI-TOF mass spectrometry identification system: VITEK® MS PRIME
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the CE-marking of VITEK® MS PRIME, the next generation of the VITEK® MS MALDI-TOF mass spectrometry system for routine mi...
-
27 Apr 2021
bioMérieux – First-Quarter 2021 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the three months ended March 31, 2021.
-
21 Apr 2021
bioMérieux - First Quarter 2011 Business Review
Marcy L'Etoile, France - April 21, 2011. Sales growth: 3.5% like-for-like Strong momentum in North America Temporary slowdown in China and India Robust growth in clinical microbiology 2011 sales growt...
-
07 Apr 2021
bioMérieux announces the CE marking of 3 dengue immunoassays on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated assays to diagnose dengue infection: VIDAS® DENGUE NS1 Ag VIDAS® Anti-DE...
-
24 Mar 2021
bioMérieux announces the CE marking of TB IGRA® test on VIDAS®
Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interfe...
-
18 Mar 2021
BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 obtains De Novo FDA Authorization
Marcy l’Étoile (France) – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious diseas...
-
09 Mar 2021
The Biotech Digital Campus joins forces with biotechnology schools and training organizations to develop the talents of tomorrow
An unprecedented alliance serving the French bioproduction sector "Recipient of a Future Investment Program award" The Biotech Digital Campus is a recipient of the Engineering Action for innovative pr...
-
24 Feb 2021
bioMérieux – 2020 Financial Results
€3,118 million in full-year 2020 sales, up 19.7 % like-for-like Robust sales performance in the fourth quarter, with organic growth of 20.5 % led by sales of molecular biology reagents Contributive op...
-
03 Feb 2021
bioMérieux announces the CE marking of NEPHROCHECK® test on VIDAS®
Marcy l’Etoile, France – February 3rd , 2021 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced the CE marking of the innovative NEPHROCHECK® assay to detect kidney str...
-
16 Dec 2020
bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses
Marcy l’Etoile, France – December 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the real-time PCR (RT-PCR) detection ...
-
14 Dec 2020
Increased outlook for full-year 2020
Marcy l'Étoile, December 14, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2020.
-
14 Dec 2020
The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
An ambitious goal to develop the skills necessary for health independence...
-
02 Dec 2020
BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology
Lyon, December 2, 2020 - BIOASTER Microbiology Technology Research Institute announced a strategic partnership in the field of sequencing-based diagnostics in microbiology with the Université de Techn...